| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918103 | Radiotherapy and Oncology | 2015 | 8 Pages |
Abstract
FS I-125 BT reduces urethral and bladder dose significantly compared to TS. With TS, there is an increased risk of cumulative dose and severe GU toxicity. Based on these findings, bladder D2Â cc should be below 70Â Gy and urethral V100 below 0.40Â cc.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Max Peters, Jochem van der Voort van Zyp, Carel Hoekstra, Hendrik Westendorp, Sandrine van de Pol, Marinus Moerland, Metha Maenhout, Rob Kattevilder, Marco van Vulpen,